Current Pharmacogenomics and Personalized Medicine
Title:Meet Our Associate Editor
Volume: 16 Issue: 2
Author(s): Bipin Nair
Affiliation:
Export Options
About this article
Cite this article as:
Nair Bipin , Meet Our Associate Editor, Current Pharmacogenomics and Personalized Medicine 2018; 16 (2) . https://dx.doi.org/10.2174/187569211602181008105152
DOI https://dx.doi.org/10.2174/187569211602181008105152 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design Salvia miltiorrhiza in Anti-diabetic Angiopathy
Current Molecular Pharmacology Arterial Stiffness and Cardiovascular Drugs
Current Pharmaceutical Design Inflammation: A Link Between Hypertension and Atherosclerosis
Current Hypertension Reviews Role of the Sympathetic Nervous Activity in Hypertension-Update in 2013
Current Hypertension Reviews Dendritic Cell Immunotherapy for Acute Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Application of MALDI/SELDI Mass Spectrometry to Cancer Biomarker Discovery and Validation
Current Proteomics Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature
Current Molecular Medicine Modulation of Small Artery Function by Insulin in Young Women: Role of Adiposity
Endocrine, Metabolic & Immune Disorders - Drug Targets Pegylated Nanoparticles for Brain Targeting- Opportunities and Challenges
Current Nanomedicine The Research Progress of DPP-4 Inhibitors
Mini-Reviews in Medicinal Chemistry Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy
Current Drug Discovery Technologies Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
Current Pharmaceutical Design Alzheimers Disease Drug Development: Old Problems Require New Priorities
CNS & Neurological Disorders - Drug Targets The Post Hoc Use of Randomised Controlled Trials to Explore Drug Associated Cancer Outcomes: Methodological Challenges
Current Drug Safety Homocysteine in Neurological Disease: A Marker or a Cause?
CNS & Neurological Disorders - Drug Targets Recent Patents on Oral Combination Drug Delivery and Formulations
Recent Patents on Drug Delivery & Formulation Advances in Nanomaterial-based Biosensors for Determination of Glycated Hemoglobin
Current Topics in Medicinal Chemistry Stem Cell Therapies for the Treatment of Diabetic Neuropathies: Future Perspectives
Current Diabetes Reviews Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
Current Medicinal Chemistry